Introducción: El tumor filoide de mama, es una neoplasia fibroepitelial rara, de crecimiento rápido, que representa del 0,3% al 1% de todos los tumores de mama. Se clasifican de acuerdo a su histopatología en, benignos, lo cual representa su gran mayoría, malignos y limítrofes. Clínicamente tienen un crecimiento rápido, son indoloros, recidivantes y deforman extraordinariamente la mama. La importancia en el diagnóstico precoz radica en evitar el desarrollo de complicaciones mayores o que se permita el progreso de una neoplasia cuando se trata de un tumor filoides maligno. El tratamiento va a depender del tipo histológico del tumor y el seguimiento se considera un proceso fundamental. Objetivo: Describir un caso clínico de Tumor filoides de mama y revisión bibliográfica de su presentación clínica, tipos histológicos, diagnóstico y tratamiento. Materiales y Métodos:Se realiza revisión exhaustiva de artículos científicos, consultando las bases de datos PUBMED, ELSEVIER, EPISTEMONIKOS, MedLine, The Cochranre Library Plus, seleccionándose artículos en su mayoría del año 2017 en adelante, en los idiomas español e inglés. Se revisaron artículos completos y resúmenes sobre el tema.Resultados: Se seleccionaron 30 artículos. Artículos de revisión, meta-análisis, estudios observacionales, descriptivos, retrospectivos, opiniones de autores y normas de la Red Nacional Integral del Cáncer. Se realizó un Estudio descriptivo, retrospectivo, para presentación de caso clínico correspondiente a Tumor filoides. Se presenta el caso clínico de paciente de sexo femenino de 27 años de edad que manifiesta una tumoración en mama derecha de gran tamaño, indolora, que produce deformidad, de dos meses de evolución, cuya histopatología corresponde a un tumor filoides benigno y que recibe tratamiento quirúrgico realizándose cirugía conservadora de la mama. Conclusiones: El tumor filoide es una neoplasia fibroepitelial infrecuente, clínicamente se puede confundir con un fibroadenoma, debe ser diagnosticado a tiempo mediante histopatología, debe determinarse el subtipo de tumor, ya que puede ser benigno, maligno o limítrofe y su tratamiento va a depender de su patrón histopatológico, pudiendo realizarse cirugía conservadora de la mama, mastectomía y en casos de tumores malignos infiltrantes y metastásicos se puede complementar con radioterapia y quimioterapia adyuvante
BACKGROUND: Diabetes mellitus is a major public health problem, according to the World Health Organization, 422 million adults worldwide in 2014. In 2012, it caused 1.5 million deaths worldwide. Diabetes is the leading cause of non-traumatic amputation in lower limbs and foot infections occur with high frequency in poorly controlled patients. This case shows the reconstruction of soft tissue defects in the lower third leg, heel, malleoli and foot through the description of the reverse sural flap. In this study the advantages and disadvantages of the use of this technique are discussed. CASE REPORT: A 56-year-old female patient with a poorly controlled history of Diabetes Mellitus type 2, who suffered a fracture of the left ankle treated with osteosynthesis, and who during the postoperative period attended emergency orthopedics and traumatology, due to severe pain in the left ankle, fever, dehiscence of surgical wound, accompanied by serous secretion. EVOLUTION: The patient, after several surgical cleanings and changes in closure therapy assisted by negative pressure, manages to control the infection, with persistence of the bone coverage defect and the osteosynthesis material. There were additional complications such as joint stiffness, muscle atrophy; it was decided to reconstruct the distal third of the foot using a reverse flow sural fasciocutaneous flap, which evolved satisfactorily, managing to cover the defect with biological tissue. CONCLUSIONS: The sural flap of reverse flow is a reproducible technique that allows to cover coverage defects in the distal third of the leg and ankle; shorten hospitalization times, especially when there is bone exposure or osteosynthesis material.
BACKGROUND: The epiphysiolysis of the femoral head is the displacement of the epiphysis with respect to the metaphysis, in anterosuperior direction; it is etiology is unknown, frequent in adolescents, peripubertal period, and with high body mass index, average age between 12 and 18 years. It is incidence is variable, 0.2 (Japan) to 10 (United States) per 100 000 inhabitants. It is characterized by progressive pain in the hip, with irradiation to the groin or knee, is associated with lameness; with the early detection, an adequate treatment can be established, the most accepted one is the in situ fixation with central screws. CASE REPORT: A 14-year-old female patient with no pathological history attended the Children's Orthopedic Service due to the chronic lancinating pain of the right hip, which increases with walking, it is diagnosed by clinical examination and complementary exams of femoral head epiphysiolysis. Surgical dislocation of the hip and anatomical open reduction with placement of spongy screws was performed. EVOLUTION: On the third day of surgery, hospital discharge is decided; walking with crutches and without support during a postoperative month. The osteosynthesis remained for a year with monthly controls and corresponding physiotherapy; it has been evidenced favorable evolution; hip mobility arches preserved, normal ambulation, without complications CONCLUSIONS: The initial treatment of a patient with epiphysiolysis of stable femoral head depends on the evolution time and is done by fixing with screws or needles with of anatomical dislocation of the hip and osteoplasty of femoral neck remodeling. Most patients do not develop necrosis or chondro- lysis and long-term results with in situ fixation are usually excellent, unlike patients with late diagnosis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.